Literature DB >> 7627624

Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection.

V Navikas1, J Link, C Persson, T Olsson, B Höjeberg, A Ljungdahl, H Link, B Wahren.   

Abstract

Evidence has been presented for the involvement of various cytokines, including interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-alpha, in the pathogenesis of human immunodeficiency virus (HIV) infection. Since measured plasma levels may poorly reflect in vivo production of cytokines, we adopted in situ hybridization with cDNA oligonucleotide probes to enumerate blood mononuclear cells (MNCs) expressing mRNA for IL-6, IL-10, TNF-alpha, and perforin. The HIV-infected patients had elevated levels of MNCs expressing mRNA for all four cytokines compared to healthy controls. Numbers of IL-6 mRNA-expressing cells were higher in patients with clinical AIDS than in asymptomatic seropositive patients, and correlated inversely with CD4+ cell counts in blood, reflecting the involvement of IL-6 in later stages of HIV infection. The described approach could be an alternative way to study cytokines in HIV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627624

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  16 in total

1.  Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.

Authors:  L Al-Harthi; K A Roebuck; A Landay
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

2.  Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients.

Authors:  G Hittinger; C Poggi; E Delbeke; N Profizi; A Lafeuillade
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

3.  Interactions between opportunistic micro-organisms and HIV in the lung.

Authors:  J R Clarke; D Israel-Biet
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

4.  Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection.

Authors:  Philip J Norris; Brandee L Pappalardo; Brian Custer; Gerald Spotts; Frederick M Hecht; Michael P Busch
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

Review 5.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

6.  Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components.

Authors:  D Delfino; L Cianci; E Lupis; A Celeste; M L Petrelli; F Curró; V Cusumano; G Teti
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier.

Authors:  Anathbandhu Chaudhuri; Bo Yang; Howard E Gendelman; Yuri Persidsky; Georgette D Kanmogne
Journal:  Blood       Date:  2007-11-14       Impact factor: 22.113

8.  Estimation of mRNA levels of interleukin (IL)-10, tumor necrosis factor (TNF)-α, IL-4 and interferon (IFN)-γ in HIV infected children in Mumbai.

Authors:  Sweta T Kothari; Ranjana A Deshmukh
Journal:  Indian J Clin Biochem       Date:  2006-03

Review 9.  Networking at the level of host immunity: immune cell interactions during persistent viral infections.

Authors:  Cherie T Ng; Laura M Snell; David G Brooks; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

10.  Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.

Authors:  Vincent Quivy; Emmanuelle Adam; Yves Collette; Dominique Demonte; Alain Chariot; Caroline Vanhulle; Ben Berkhout; Rémy Castellano; Yvan de Launoit; Arsène Burny; Jacques Piette; Vincent Bours; Carine Van Lint
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.